AnalystsSean LeeSean Lee's Stock Forecasts
AnalystsSean Lee
Sectors:
Industries:
Analyst Ranking
Top 27%
#1299 out of 4875 analysts
Average Return
+2.52%
Win Rate
30%27 out of 90
Risk vs Reward
Poor
Good
Sean Lee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | +1,072.87% | $3.36 | $39.42 | 2024-05-10 - 2025-05-09 | Buy |
Alphatec Holdings IncATEC | +346.70% | $3.94 | $17.60 | 2020-04-09 - 2021-04-09 | Buy |
Verastem IncVSTM | +209.05% | $2.32 | $7.17 | 2024-08-12 - 2025-05-09 | Buy |
Casi Pharmaceuticals IncCASI | +195.45% | $2.20 | $6.50 | 2023-08-14 - 2024-08-13 | Buy |
Verastem IncVSTM | +142.23% | $2.96 | $7.17 | 2024-10-18 - 2025-05-09 | Buy |
Sean Lee Analyst Color
Get additional color on Sean Lee's coverage of popular stocks
Sean Lee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Verastem IncVSTM | 14 | Buy | $14.00 | +95.26% | Maintains | 2 days ago |
Dogwood Therapeutics IncDWTX | 4 | Buy | $10.00 | +119.30% | Upgrades | 18 days ago |
Alphatec Holdings IncATEC | 11 | Buy | $20.00 | +63.80% | Reiterates | a month ago |
Casi Pharmaceuticals IncCASI | 8 | Buy | $4.00 | +112.20% | Maintains | a month ago |
Cytosorbents CorpCTSO | 12 | Hold | $1.00 | +14.81% | Reiterates | a month ago |
Monopar TherapeuticsMNPR | 9 | Buy | $40.00 | +1.47% | Reiterates | a month ago |
Plus Therapeutics IncPSTV | 11 | Buy | $5.50 | +733.33% | Maintains | a month ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $11.00 | +148.31% | Reiterates | 2 months ago |
Myomo IncMYO | 5 | Buy | $9.50 | +196.88% | Maintains | 2 months ago |
Gritstone Bio IncGRTSQ | 12 | Hold | $0.50 | +1,462.50% | Downgrades | 7 months ago |
Kazia Therapeutics LtdKZIA | 4 | Buy | $100.00 | +2,662.43% | Reiterates | 10 months ago |
Thermogenesis Holdings IncTHMO | 6 | Buy | $5.00 | N/A | Reiterates | a year ago |
Akari Therapeutics PLCAKTX | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Aceragen IncACGN | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.